OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antisense oligonucleotide therapy in an individual with KIF1A-associated neurological disorder
Alban Ziegler, Joanne Carroll, Jennifer Bain, et al.
Nature Medicine (2024) Vol. 30, Iss. 10, pp. 2782-2786
Closed Access | Times Cited: 7
Alban Ziegler, Joanne Carroll, Jennifer Bain, et al.
Nature Medicine (2024) Vol. 30, Iss. 10, pp. 2782-2786
Closed Access | Times Cited: 7
Showing 7 citing articles:
A Two-Heads-Bound State Drives KIF1A Superprocessivity
Lu Rao, Jan Otto Wirth, Jessica Matthias, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Lu Rao, Jan Otto Wirth, Jessica Matthias, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Addressing the Needs of Nano-Rare Patients
Stanley T. Crooke
Nucleic Acid Therapeutics (2025)
Closed Access
Stanley T. Crooke
Nucleic Acid Therapeutics (2025)
Closed Access
Distinct Clinical Phenotypes in KIF1A-Associated Neurological Disorders Result from Different Amino Acid Substitutions at the Same Residue in KIF1A
Lu Rao, Wenxing Li, Yufeng Shen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Lu Rao, Wenxing Li, Yufeng Shen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Consensus guidelines for assessing eligibility of pathogenic DNA variants for antisense oligonucleotide treatments
David Cheerie, Margaret Meserve, Danique Beijer, et al.
The American Journal of Human Genetics (2025)
Open Access
David Cheerie, Margaret Meserve, Danique Beijer, et al.
The American Journal of Human Genetics (2025)
Open Access
Antisense oligonucleotide treatment in a preterm infant with early-onset SCN2A developmental and epileptic encephalopathy
Matias Wagner, Géza Berecki, Walid Fazeli, et al.
Nature Medicine (2025)
Open Access
Matias Wagner, Géza Berecki, Walid Fazeli, et al.
Nature Medicine (2025)
Open Access
Advancing ASO therapies from development to implementation
Rebecca Schuele, Matthis Synofzik, Holm Graeßner, et al.
Nature Medicine (2024)
Closed Access | Times Cited: 1
Rebecca Schuele, Matthis Synofzik, Holm Graeßner, et al.
Nature Medicine (2024)
Closed Access | Times Cited: 1
Antisense oligonucleotides in rare neurogenetic disorders
Hui Jin Shin, Ara Ko, Jiyoung Oh, et al.
Journal of Genetic Medicine (2024) Vol. 21, Iss. 2, pp. 41-50
Open Access | Times Cited: 1
Hui Jin Shin, Ara Ko, Jiyoung Oh, et al.
Journal of Genetic Medicine (2024) Vol. 21, Iss. 2, pp. 41-50
Open Access | Times Cited: 1
Child with ultra-rare disease gets a treatment just for her
Nature (2024) Vol. 632, Iss. 8026, pp. 711-711
Closed Access
Nature (2024) Vol. 632, Iss. 8026, pp. 711-711
Closed Access
